Traditional Chinese medicine for curing spleen and kidney deficiency type ischemic post-stroke depression

Abstract

The invention relates to a traditional Chinese medicine for curing spleen and kidney deficiency type ischemic post-stroke depression, which solves the problems of untoward reactions, such as dizziness, hypodynamia, drowsiness, thirsty mouth, constipation and intoxication, and side effects, such as hypopiesia, epilepsia, and respiratory and cardiac arrest, caused by other medication. The traditional Chinese medicine comprises 15 to 25 g of pilose asiabell root, 15 to 25 g of bighead atractylodes rhizome, 7 to 13 g of indian bread, 7 to 13 g of root of herbaceous peony, 15 to 25 g of rehmannia root, 9 to 15 g of dogwood fruit, 7 to 13 g of Indianmulberry, 7 to 13 g of kudzuvine root, 7 to 13 g of fruit of barbary wolf berry, 9 to 15 g of aucklandia root, 7 to 13 g of cyperirhizome, 23 to 37 g of fossil fragment, 23 to 37 g of oyster and 5 to 7 g of licorice root; and the material is prepared into medicinal broth through conventional soaking, boiling and filtering; or the traditional Chinese medicine is directly formed by blending commercially available single Chinese herb formula granule. The traditional Chinese medicine has obvious curative effect, improves the life quality of patients, and has safe and reliable efficacy and little side effects.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine (also known as Peiyuan Jieyu granule) for treating post-ischemic stroke depression of spleen and kidney deficiency type. Background technique [0002] Post-stroke depression (PSD) is one of the common emotional disorders and complications after stroke, mainly manifested as poor control of emotions, strong inertia, decreased willpower, strong dependence, or irritability Anxiety, disappointment and complaints, even self-defeating, suicidal tendencies, etc., are a type of secondary depression, which affect the recovery of the patient's neurological function and are an important risk factor for stroke recurrence. With the aging of the population, the incidence of cerebrovascular disease is increasing year by year, and the incidence of PSD is also increasing. At present, PSD has been paid more and more attention by Chinese and Western medici...

AI Technical Summary

Problems solved by technology

[0005] In view of the above situation, in order to overcome the defects of the prior art, the purpose of the present invention is to provide a Chinese medicine for the treatment of post-ischemic stroke depression of spleen and kidney deficiency type, which can effectively alleviate clinical depression symptoms and promote the recovery of neurological function. Improve or solve the adverse reactions such as dizziness, fatigue, drowsiness, dry mouth, constipation and overdose that are easily caused by other commonly used drugs in the treatment of post-stroke depression, as well as side effects such as hypotension, epilepsy, respiratory and cardiac arrest, etc.

Images